ANEST IWATA Corporation
Anest Iwata Corporation Q1 FY2027 Financial Summary (Japanese GAAP) (Consolidated) for the Fiscal Year Ending March 2027
The consolidated results for the first quarter of the fiscal year ending March 2027 show net sales of 13,700 million yen (up 13.3% YoY), operating profit of 1,234 million yen (up 32.8% YoY), ordinary profit of 1,763 million yen (up 34.1% YoY), and net income attributable to owners of the parent of 1,137 million yen (up 27.0% YoY), marking a substantial earnings increase. The goodwill arising from the consolidation of the new subsidiary SANWA is included. Full-year guidance is expected to be revised.
Key Figures
- Net sales: 13,700百万円（YoY +13.3%）
- Operating profit: 1,234百万円（YoY +32.8%）
- Ordinary profit: 1,763百万円（YoY +34.1%）
AI要約
Overview of Performance
The first quarter of this fiscal year posted a 13.3% increase in net sales vs. the prior year, with solid momentum across Japan, Asia, Europe, the Americas, and Greater China/ASEAN as well. Goodwill was recorded due to the consolidation of the new subsidiary SANWA. Overall, there is an ongoing improvement in profitability.
Outlook and Considerations
The full-year earnings forecast for the FY ending March 2027 is expected to be revised. Potential impacts include geopolitical risks, supply chain dynamics, and contributions from the new subsidiary. An earnings briefing material will be prepared, but no investor briefing will be held.
Anest Iwata Corporation
Company overview · Stock price · Financial data · All IR
